RecruitingNot ApplicableNCT06946732

Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism

Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism (The ARTIST Study)

Sponsor

RenJi Hospital

Enrollment

127 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Pulmonary Embolism (PE)

Summary

The registry is to evaluate the safety and feasibility of catheter-directed aspiration for patients with high-risk and intermediate-high-risk pulmonary embolism using Acostream.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Acostream aspiration for people with pulmonary embolism (pe). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.